TRASTUZUMAB AND HYALURONIDASE-OYSK

TRASTUZUMAB AND HYALURONIDASE-OYSK was reported 107 times

TRASTUZUMAB AND HYALURONIDASE-OYSK is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACQUIRED HAEMOGLOBINOPATHY 1 0.2000
1 CRYOTHERAPY 1 0.0135
2 TESTICULAR FAILURE 1 0.0073
3 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
4 LACK OF ADMINISTRATION SITE ROTATION 1 0.0033
5 TONGUE EXFOLIATION 1 0.0028
6 TOTAL LUNG CAPACITY ABNORMAL 1 0.0026
7 FACTOR V LEIDEN MUTATION 1 0.0025
8 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
9 LOCAL REACTION 1 0.0013
10 LIP ERYTHEMA 1 0.0013
11 TUMOUR EXCISION 1 0.0012
12 TONGUE ERYTHEMA 1 0.0012
13 APTYALISM 1 0.0012
14 INTERCEPTED PRODUCT STORAGE ERROR 3 0.0008
15 SEROMA 1 0.0008
16 DACRYOSTENOSIS ACQUIRED 1 0.0008
17 TUMOUR PAIN 1 0.0008
18 NORMOCYTIC ANAEMIA 1 0.0007
19 GENERALISED ANXIETY DISORDER 1 0.0007
20 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
21 PLEURITIC PAIN 1 0.0004
22 ACNE CYSTIC 1 0.0003
23 BREAST CANCER RECURRENT 1 0.0003
24 WOUND DEHISCENCE 1 0.0003
25 THROMBOCYTOSIS 1 0.0003
26 EPIGASTRIC DISCOMFORT 1 0.0003
27 TONGUE DISCOLOURATION 1 0.0002
28 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
29 PHLEBITIS 1 0.0002
30 SENSITIVITY TO WEATHER CHANGE 1 0.0002
31 ERYTHEMA OF EYELID 1 0.0002
32 HYPERCHLORHYDRIA 1 0.0002
33 NO ADVERSE EVENT 30 0.0002
34 INCOHERENT 1 0.0002
35 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
36 LYMPHOEDEMA 1 0.0001
37 FORMICATION 1 0.0001
38 TONGUE DISORDER 1 0.0001
39 MAJOR DEPRESSION 1 0.0001
40 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
41 SKIN HYPERPIGMENTATION 1 0.0001
42 HYSTERECTOMY 1 0.0001
43 NAIL DISORDER 1 0.0001
44 EXOSTOSIS 1 0.0001
45 PNEUMONIA BACTERIAL 1 0.0001
46 BRAIN NEOPLASM 1 0.0001
47 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
48 PRODUCT ADMINISTRATION ERROR 2 0.0001
49 WEIGHT FLUCTUATION 1 0.0001
50 PERICARDIAL EFFUSION 2 0.0001
51 PRODUCT STORAGE ERROR 7 0.0001
52 INJECTION SITE IRRITATION 1 0.0001
53 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
54 HIATUS HERNIA 1 0.0001
55 EYE HAEMORRHAGE 1 0.0001
56 SEASONAL ALLERGY 1 0.0001
57 HYPOACUSIS 3 0.0001
58 STOMATITIS 4 0.0001
59 HIP ARTHROPLASTY 1 0.0001
60 OBESITY 1 0.0001
61 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
62 MUSCULOSKELETAL DISCOMFORT 1 0.0001
63 HEPATIC STEATOSIS 1 0.0001
64 NEUROPATHY PERIPHERAL 5 0.0001
65 SLEEP APNOEA SYNDROME 1 0.0001
66 SINUS DISORDER 1 0.0001
67 CYTOKINE RELEASE SYNDROME 1 0.0000
68 TASTE DISORDER 1 0.0000
69 PULMONARY HYPERTENSION 1 0.0000
70 EATING DISORDER 1 0.0000
71 IRRITABLE BOWEL SYNDROME 1 0.0000
72 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
73 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
74 HEPATOTOXICITY 1 0.0000
75 GLOSSODYNIA 1 0.0000
76 PANCREATITIS ACUTE 1 0.0000
77 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
78 PRODUCT PRESCRIBING ERROR 1 0.0000
79 PRESYNCOPE 1 0.0000
80 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
81 HAEMATOMA 1 0.0000
82 BREAST CANCER FEMALE 1 0.0000
83 ASCITES 1 0.0000
84 LACRIMATION INCREASED 1 0.0000
85 BONE DENSITY DECREASED 1 0.0000
86 IMPAIRED HEALING 1 0.0000
87 SKIN DISORDER 1 0.0000
88 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
89 LYMPHADENOPATHY 1 0.0000
90 EPISTAXIS 2 0.0000
91 COLITIS 1 0.0000
92 OFF LABEL USE 23 0.0000
93 INJECTION SITE PAIN 8 0.0000
94 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
95 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
96 SKIN DISCOLOURATION 1 0.0000
97 SWELLING 2 0.0000
98 CONTUSION 2 0.0000
99 LUNG DISORDER 1 0.0000
100 LEUKOPENIA 1 0.0000
101 FLUSHING 2 0.0000
102 CHEST DISCOMFORT 2 0.0000
103 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
104 ANAPHYLACTIC REACTION 1 0.0000
105 MEDICATION ERROR 1 0.0000
106 ASTHMA 2 0.0000
107 BONE PAIN 1 0.0000
108 NASAL CONGESTION 1 0.0000
109 IRRITABILITY 1 0.0000
110 DISCOMFORT 1 0.0000
111 FEELING HOT 1 0.0000
112 PRODUCT USE ISSUE 3 0.0000
113 RHINORRHOEA 1 0.0000
114 DEEP VEIN THROMBOSIS 1 0.0000
115 ALOPECIA 3 0.0000
116 FEBRILE NEUTROPENIA 1 0.0000
117 HEPATIC ENZYME INCREASED 1 0.0000
118 WEIGHT DECREASED 4 0.0000
119 BURNING SENSATION 1 0.0000
120 ACNE 1 0.0000
121 CHRONIC KIDNEY DISEASE 1 0.0000
122 DIABETES MELLITUS 1 0.0000
123 DRY MOUTH 1 0.0000
124 RENAL IMPAIRMENT 1 0.0000
125 URINARY TRACT INFECTION 2 0.0000
126 COVID-19 2 0.0000
127 DIARRHOEA 7 0.0000
128 PULMONARY EMBOLISM 1 0.0000
129 ANAEMIA 2 0.0000
130 PAIN IN EXTREMITY 3 0.0000
131 SYNCOPE 1 0.0000
132 SOMNOLENCE 2 0.0000
133 PAIN 6 0.0000
134 ERYTHEMA 2 0.0000
135 PLATELET COUNT DECREASED 1 0.0000
136 SEPSIS 1 0.0000
137 MUSCULAR WEAKNESS 1 0.0000
138 DECREASED APPETITE 2 0.0000
139 CHILLS 1 0.0000
140 DISEASE PROGRESSION 1 0.0000
141 VISUAL IMPAIRMENT 1 0.0000
142 INJECTION SITE ERYTHEMA 1 0.0000
143 HYPERHIDROSIS 1 0.0000
144 NAUSEA 6 0.0000
145 INSOMNIA 2 0.0000
146 VISION BLURRED 1 0.0000
147 INFECTION 1 0.0000
148 RASH 3 0.0000
149 PARAESTHESIA 1 0.0000
150 DRUG INTERACTION 1 0.0000
151 URTICARIA 1 0.0000
152 MYALGIA 1 0.0000
153 CHEST PAIN 1 0.0000
154 HYPERSENSITIVITY 1 0.0000
155 BLOOD GLUCOSE INCREASED 1 0.0000
156 FATIGUE 4 0.0000
157 HYPOTENSION 1 0.0000
158 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
159 ARTHRALGIA 2 0.0000
160 HYPERTENSION 1 0.0000
161 DEATH 4 0.0000
162 MALAISE 2 0.0000
163 WEIGHT INCREASED 1 0.0000
164 DEPRESSION 1 0.0000
165 ABDOMINAL PAIN 1 0.0000
166 COUGH 1 0.0000
167 DYSPNOEA 2 0.0000
168 PRODUCT DOSE OMISSION ISSUE 1 0.0000
169 PYREXIA 1 0.0000
170 ASTHENIA 1 0.0000
171 PRURITUS 1 0.0000
172 VOMITING 1 0.0000
173 DIZZINESS 1 0.0000
174 HEADACHE 1 0.0000
175 DRUG INEFFECTIVE 1 0.0000